Watch Ticker

NovaBay Pharmaceuticals, Inc.

Go to NovaBay Pharmaceuticals, Inc. Website

$0.61

0.00 (0.00%)

Live

Previous Close

$0.610976

Day Range

$0 - $0

Previous Day Range

$0.61 - $0.6199

Market Cap

$3.5 million USD

Day Vol.

Previous Day Vol.

81650

Currency

USD

Primary Exchange

NYSE American, LLC

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is ...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Researchandmarkets.Com - Impetigo Drugs Global Strategic Business Report 2024 - Fusidane Drug Segment is Expected to Reach US$883.5 Million by 2030, with a CAGR of a 5.1%

The global impetigo drugs market is expected to grow at a CAGR of 4.5% from 2023 to 2030, driven by factors such as the increasing incidence of impetigo, technological advancements in drug delivery, and the development of new antibiotics to combat antibiotic resistance.

Related tickers: GSK, NBY, NVS, PCVX.

Read Full Article

Investing.Com - NovaBay slashes prices on eyecare products for Amazon Prime Day - Investing.com

NovaBay Pharmaceuticals is offering a 20% discount on its Avenova-branded eyecare products during Amazon Prime Day, aligning with National Dry Eye Awareness Month. The company aims to attract new and existing customers through this promotion, which comes amid growing sales of its products through online channels.

Related tickers: NBY, AMZN.

Read Full Article

Trending Tickers

Please sign in to view